Oppenheimer analyst Leland Gershell raised the price target on Acceleron Pharma (NASDAQ: XLRN) to $120.00 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE